Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast vs Methotrexate as Add-on in Oral Lichen Planus
NCT06260904Phase 4Completed
- Sponsor
- AIIMS New Delhi
- Start
- Jan 2024
- Primary completion
- Oct 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of apremilast, methotrexate in oral lichen planus (OLP), sponsored by AIIMS New Delhi. Started Jan 2024; status: completed.
02
Drugs
apremilastmethotrexate
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT06260904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06260904.